Chairman & Managing Director
Dr BPS Reddy, CMD of Hetero Group of Companies founded the company in 1993 through an initial purchase of an API manufacturing facility. Over the past 20 years, he has nurtured this company to emerge as the largest closely held pharmaceutical company in India and a world leader in the production of anti-retroviral drugs.
Under his leadership, Hetero played a significant role during the HIV/AIDS crisis by developing one of the first affordable APIs for anti-retroviral drugs. The company today is globally acknowledged for its pioneering efforts in manufacturing a wide range of anti-retroviral drugs at an affordable cost.
Before Hetero had its humble beginnings, Dr BPS Reddy was associated with Dr Reddys Labs as the Head of Research and Development, where he successfully led the teams during their first ever FDA audit.
At Hetero, Dr BPS Reddy leveraged his expertise in synthetic chemistry and leadership roles in Research and Development to create one of the best generic API companies of the world. He is also credited for his vision on ARVs where Hetero is a significant market player today.
We are privileged to have Dr BPS Reddy as our founder and Chairman. He has enabled Hetero to become a global player with unparalleled strengths in research, manufacturing, and marketing. His vision for the advancement of healthcare has contributed to improve lives for millions of people.